Literature DB >> 19673451

[Internuclear ophthalmoplegia--causes, symptoms and management].

Iwona Obuchowska1, Zofia Mariak.   

Abstract

Internuclear ophthalmoplegia (INO) is a disorder of eye movements caused by a lesion in an area of the brain called the medial longitudinal fasciculus (MLF). The most common causes of INO are multiple sclerosis and brainstem infarction. Other causes include head trauma, brainstem and fourth ventricular tumors, Arnold-Chiari malformation, infection, hydrocephalus, and lupus erythematosus. Internuclear ophthalmoplegia is clinically characterized by total or partial failure to adduct one eye in lateral gaze and a monocular nystagmus of the abducting eye. It may be unilateral and bilateral. The method of choice for diagnostic imaging of MLF lesion in patients with INO is magnetic resonance. In this article authors present current opinion about pathogenesis, clinical symptoms, and management in patients with inter nuclear ophthalmoplegia.

Entities:  

Mesh:

Year:  2009        PMID: 19673451

Source DB:  PubMed          Journal:  Klin Oczna        ISSN: 0023-2157


  5 in total

1.  Artery of Percheron infarct: hiding in plain sight.

Authors:  Charles Badu-Boateng; Dhaarica Jeyanesan; Jonathan Easaw; Mark Lloyd
Journal:  Clin Med (Lond)       Date:  2021-07       Impact factor: 2.659

2.  Unilateral internuclear ophthalmoplegia after minor head injury.

Authors:  Richard Bamford; Gurpreet Singh-Ranger
Journal:  West J Emerg Med       Date:  2012-02

3.  Bilateral internuclear and internal ophthalmoplegia due to artery of Percheron infarction.

Authors:  Pushpa Raj Puri; Astha Sijapati
Journal:  Clin Case Rep       Date:  2017-02-01

4.  Uveitis and internuclear ophthalmoplegia as ocular manifestations of sarcoidosis.

Authors:  Daniele Cirone; Luca Cimino; Giovanni Spinucci
Journal:  Saudi J Ophthalmol       Date:  2018-01-04

5.  Bilateral Internuclear Ophthalmoplegia in a Young Woman with Vertebral Artery Dissection.

Authors:  Omar Cárdenas; Enrique Gomez; Mariana Marcín; Adib Jorge de Sarachaga; Verónica Sánchez; Juan Manuel Calleja
Journal:  Eur J Case Rep Intern Med       Date:  2019-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.